Raffi Asadorian
2017 - AcelRx Pharmaceuticals
In 2017, Raffi Asadorian earned a total compensation of $606.3K as Chief Financial Officer at AcelRx Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $34,200 |
|---|---|
| Option Awards | $420,087 |
| Salary | $150,000 |
| Other | $2,000 |
| Total | $606,287 |
Asadorian received $420.1K in option awards, accounting for 69% of the total pay in 2017.
Asadorian also received $34.2K in non-equity incentive plan, $150K in salary and $2K in other compensation.
Rankings
In 2017, Raffi Asadorian's compensation ranked 11,151st out of 14,666 executives tracked by ExecPay. In other words, Asadorian earned more than 24.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,151 out of 14,666 | 24th |
Division Manufacturing | 4,363 out of 5,772 | 24th |
Major group Chemicals And Allied Products | 1,581 out of 2,075 | 24th |
Industry group Drugs | 1,301 out of 1,731 | 25th |
Industry Pharmaceutical Preparations | 1,015 out of 1,333 | 24th |
Source: SEC filing on April 23, 2018.
Asadorian's colleagues
We found seven more compensation records of executives who worked with Raffi Asadorian at AcelRx Pharmaceuticals in 2017.
2017
Vincent Angotti
AcelRx Pharmaceuticals
Chief Executive Officer
2017
Pamela Palmer
AcelRx Pharmaceuticals
Chief Medical Officer
2017
Howard Rosen
AcelRx Pharmaceuticals
Chief Executive Officer
2017
Badri Dasu
AcelRx Pharmaceuticals
Chief Engineering Officer
2017
Lawrence Hamel
AcelRx Pharmaceuticals
Chief Development Officer
2017
Timothy Morris
AcelRx Pharmaceuticals
Chief Financial Officer
2017
Jane Wright-Mitchell
AcelRx Pharmaceuticals
Chief Legal Officer
News
AcelRx Pharmaceuticals CEO Vincent Angotti's 2023 pay slips 7% to $1.2M
April 29, 2024
AcelRx Pharmaceuticals CEO Vincent Angotti's 2022 pay falls 47% to $1.3M
August 28, 2023
AcelRx Pharmaceuticals CEO Vincent Angotti's 2021 pay jumps 39% to $2.4M
June 3, 2022
AcelRx Pharmaceuticals CEO Vincent Angotti's 2019 pay jumps 22% to $2.1M
April 24, 2020
AcelRx Pharmaceuticals CEO Vincent Angotti's 2018 pay falls 26% to $1.7M
May 14, 2019